Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 103

1.

Normotensive renal failure in a patient with systemic sclerosis and p-antineutrophil cytoplasmic autoantibodies which developed into Paget's disease of bone after immunosuppressive therapy.

Villaverde V, Balsa A, Cabezas JA, Fernández-Prada M, Torre A, Mola EM.

Rheumatology (Oxford). 1999 Feb;38(2):190-1. No abstract available.

2.
3.

Antineutrophil cytoplasmic autoantibodies in 6 patients with renal failure and systemic sclerosis.

Endo H, Hosono T, Kondo H.

J Rheumatol. 1994 May;21(5):864-70.

PMID:
8064727
4.

Systemic sclerosis and antineutrophil cytoplasmic autoantibody-associated renal failure.

Katrib A, Sturgess A, Bertouch JV.

Rheumatol Int. 1999;19(1-2):61-3.

PMID:
10651085
5.

Antineutrophil cytoplasmic autoantibodies in systemic sclerosis with renal failure.

Huong DL, Papo T, Gatfosse M, Frances C, Godeau P, Beaufils H.

J Rheumatol. 1995 Apr;22(4):791-2. No abstract available.

PMID:
7791189
6.

Antineutrophil cytoplasmic autoantibodies (ANCA) and systemic sclerosis.

Carvajal I, Bernis C, Sanz P, Garcia A, Garcia-Vadillo A, Traver JA.

Nephrol Dial Transplant. 1997 Mar;12(3):576-7. No abstract available.

7.

Scleroderma associated with ANCA-associated vasculitis.

Rho YH, Choi SJ, Lee YH, Ji JD, Song GG.

Rheumatol Int. 2006 Mar;26(5):465-8.

PMID:
16012875
8.

Antineutrophil cytoplasmic antibodies a "Red Flag" in patients with systemic sclerosis.

Casari S, Haeney M, Farrand S, Herrick A.

J Rheumatol. 2002 Dec;29(12):2666-7. No abstract available.

9.

ANCA-related crescentic glomerulonephritis in a patient with scleroderma without marked dermatological change and malignant hypertension.

Tomioka M, Hinoshita F, Miyauchi N, Akiyama Y, Saima S, Hiroe M.

Intern Med. 2004 Jun;43(6):496-502. Review.

10.

Scleroderma with type III glomerulonephritis and MPO-ANCA antibodies in the serum.

Herrera-Esparza R, Aguilar JL, Saucedo A, González I, López-Robles E, Avalos-Díaz E.

J Eur Acad Dermatol Venereol. 2005 Sep;19(5):617-20.

PMID:
16164722
11.

Antineutrophil cytoplasmic antibodies in scleroderma patients: first report of a case with anti-proteinase 3 antibodies and review of the literature.

Caramaschi P, Biasi D, Tonolli E, Carletto A, Bambara LM.

Joint Bone Spine. 2002 Mar;69(2):177-80.

PMID:
12027309
12.

[Progressive systemic sclerosis associated with anti-myeloperoxidase ANCA vasculitis with renal and cutaneous involvement].

Martínez Ara J, Picazo ML, Torre A, Pascual D, Díaz Rodríguez C, Riñón C.

Nefrologia. 2000 Jul-Aug;20(4):383-6. Spanish.

13.

Antineutrophil cytoplasmic antibodies in patients with systemic sclerosis.

Manolova I, Dancheva M.

J Rheumatol. 2003 Sep;30(9):2078-9; author reply 2079-80. No abstract available.

14.

A patient with systemic sclerosis, severe cytopenias and the simultaneous presence of anti-centromere and anti-SCL-70-antibodies.

Hietarinta M, Tertti R, Lassila O.

Clin Exp Rheumatol. 1993 Jul-Aug;11(4):457-8. No abstract available.

PMID:
8403594
15.

[A case of systemic sclerosis with crescentic glomerulonephritis associated with perinuclear-antineutrophil cytoplasmic antibody (p-ANCA)].

Harashima S, Yoshizawa S, Horiuchi T, Nakashima H, Niho Y, Kusaba T, Hayashida I, Shinozaki M, Katafuchi R, Hirakata H.

Nihon Rinsho Meneki Gakkai Kaishi. 1999 Apr;22(2):86-92. Japanese.

PMID:
11126659
16.

Antineutrophil cytoplasmic antibodies in systemic sclerosis.

Kiraz S, Simsek H, Ertenli I, Benekli M, Kadayifci A.

Clin Rheumatol. 1996 Sep;15(5):519-20. No abstract available.

PMID:
8894374
17.
18.

[A case of myeloperoxidase-antineutrophil cytoplasmic antibody (MPO-ANCA) related glomerulonephritis associated with systemic sclerosis treated by steroid pulse therapy: a case report].

Mizutani A, Tanaka I, Katayama M, Oshima H, Komatsu Y, Asano S, Kato K, Matsumura H, Ishii K, Miyama H, Nagai T, Kato K, Fukaya S, Yoshida S, Hasegawa M, Kawashima S, Torikai K.

Ryumachi. 2000 Oct;40(5):828-32. Japanese.

PMID:
11215162
19.

Randomized trial of cyclophosphamide versus methotrexate for induction of remission in early systemic antineutrophil cytoplasmic antibody-associated vasculitis.

De Groot K, Rasmussen N, Bacon PA, Tervaert JW, Feighery C, Gregorini G, Gross WL, Luqmani R, Jayne DR.

Arthritis Rheum. 2005 Aug;52(8):2461-9.

20.

Autoantibodies to bactericidal/permeability-increasing protein and cathepsin G in systemic sclerosis.

Grypiotis P, Cozzi F, Ruffatti A.

J Rheumatol. 2004 Jul;31(7):1468-9. No abstract available.

Items per page

Supplemental Content

Support Center